ENTA - Enanta Pharmaceutica...

Valuation of Enanta Pharmaceuticals, Inc.(ENTA), Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs f

Enanta Pharmaceuticals, Inc.

ENTA

NASDAQ

Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and license agreement with Abbott Laboratories to identify, develop, and commercialize HCV NS3 and NS3/4A protease inhibitor compounds, including paritaprevir and glecaprevir for the treatment of chronic hepatitis C virus. Enanta Pharmaceuticals, Inc. was founded in 1995 and is headquartered in Watertown, Massachusetts.

12.37 USD

-0.11 (-0.889%)

Overview Profile Financial Statements Financial Ratios Chart Analysis News Corporate Actions DCF

Valuation Date:

Apr 26, 2024 4:00 PM

Share Price on Valuation Date

$12.37

Stock Beta

0.488

Shares Outstanding

21156000

FMP

Home Terms of Service Privacy Policy Blog FAQs Contact Us

API

Documentation Pricing Formulas Market Indexes

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.